Matsumoto Manabu, Furihata Mutsuo, Ohtsuki Yuji
Department of Clinical Laboratory, Kochi Medical School Hospital, Nankoku, Kochi, 783-8305, Japan.
Med Mol Morphol. 2006 Jun;39(2):79-87. doi: 10.1007/s00795-006-0320-0.
p53 has been called the "cellular gatekeeper" and the "genome guard," because in response to exposure to DNA-damaging agents, it induces cell-cycle arrest in G1 or apoptosis and also directly affects DNA replication. Multiple mechanisms regulate p53 activity and posttranslational modification, including multisite phosphorylation of wild-type p53, in particular. Normal functions of wild-type p53 are abrogated by mutation of this gene, and oncogenic studies have revealed that p53 mutation is among the most common genetic alteration in human cancers. It is generally accepted that mutant p53 protein may not only lose the tumor suppressor functions of wild-type p53 but also acquire additional tumorigenetic roles, including dominant-negative effects and gain of function. Although many studies have revealed such aberrant functions of mutant p53, less is known about the posttranslational phosphorylation status of mutant p53 and novel biological functions of phosphorylation in carcinogenesis.
p53被称为“细胞守门人”和“基因组卫士”,因为在受到DNA损伤剂作用时,它会诱导细胞周期在G1期停滞或引发细胞凋亡,并且还直接影响DNA复制。多种机制调节p53的活性和翻译后修饰,尤其是野生型p53的多位点磷酸化。该基因的突变会消除野生型p53的正常功能,肿瘤学研究表明p53突变是人类癌症中最常见的基因改变之一。人们普遍认为,突变型p53蛋白不仅可能丧失野生型p53的肿瘤抑制功能,还可能获得额外的致瘤作用,包括显性负效应和功能获得。尽管许多研究已经揭示了突变型p53的这种异常功能,但对于突变型p53的翻译后磷酸化状态以及磷酸化在致癌过程中的新生物学功能了解较少。